Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, March 2001, p. 962-965, Vol. 45, No. 3
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.3.962-965.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Mutations of the Helicobacter pylori
Genes rdxA and pbp1 Cause Resistance
against Metronidazole and Amoxicillin
Ralf
Paul,*,1
Stefan
Postius,2
Klaus
Melchers,2 and
Klaus
P.
Schäfer2
Yale University, New Haven, Connecticut
06511,1 and Byk Gulden
Pharmaceuticals, Konstanz, Germany2
Received 9 June 2000/Returned for modification 17 August
2000/Accepted 25 November 2000
 |
ABSTRACT |
To investigate amoxicillin and metronidazole resistance of
Helicobacter pylori, we compared putative resistance
genes between resistant strains obtained in vitro and their sensitive
parent strain. All metronidazole-resistant strains had
rdxA mutations, and an amoxicillin-resistant strain had
pbp1 and pbp2 mutations. By transforming
PCR products of these mutated genes into antibiotic-sensitive strains,
we showed that rdxA null mutations were sufficient for metronidazole resistance, while pbp1
mutations contributed to amoxicillin resistance of H.
pylori.
 |
TEXT |
Although most infections with
Helicobacter pylori are asymptomatic, and some might even be
beneficial for the host, the pathogen is usually eradicated with
antibiotics such as amoxicillin and metronidazole in order to cure
gastritis and peptic ulcer diseases (3, 4). Resistance
against metronidazole is common among H. pylori strains,
while there are only a few reports of amoxicillin-resistant H. pylori strains (6, 8; M. Guslandi, Letter, Lancet
353:241-242, 1999; A. A. van Zwet, C. M. Vandenbroucke-Grauls, J. C. E. Thijs, J. van der Wouden,
M. M. Gerrits, J. G. Kusters, and C. M. Vandenbrouke-Grauls, Letter, Lancet 352:1595, 1998).
Metronidazole resistance of H. pylori was shown to be due to
the mutational inactivation of rdxA (7, 11). In
turn, a metronidazole-resistant strain (Mtzr) was
rendered sensitive when complemented with the rdxA gene of a
metronidazole-sensitive strain (Mtzs). It was
concluded that RdxA functions as a metronidazole-reducing nitroreductase (11). Resistance against
-lactam
antibiotics like amoxicillin is generally due to hydrolysis by a
-lactamase (5) or by mutational modification of the
penicillin binding proteins (13).
To investigate the molecular basis for antibiotic resistance in
H. pylori, we did an in vitro selection for amoxicillin and metronidazole resistance on the strains 503 (ATCC 43503) and 69A (69A
and 888-0: clinical isolates obtained from R. Haas, Max-von Pettenkofer-Institut, Munich, Germany). In contrast to other
investigators (12, 15), we performed the selection not on
agar plates, but in liquid culture (brain heart infusion medium [BHI;
Difco-BD Biosciences, Md.] plus 5% fetal calf serum [FCS; Eurobio,
Les Ulis, France]) at 37°C with microaerobic incubation (5 to 6%
O2, 8 to 10% CO2) in the
presence of these antibiotics. The MIC was determined by inoculating
logarithmically growing H. pylori cells with an optical
density at 578 nm (OD578) of 0.04 in 10 ml of BHI-5% FCS in 50-ml cell culture flasks (Greiner) on a shaker incubator at 90 rpm. The MIC of metronidazole was defined as no OD578 increase in 10 to 14 days, and that of
amoxicillin was defined as growth to an OD578
lower than 0.4, with no increase after the first 24 h of
incubation. We obtained stable metronidazole resistance after three
serial passages over the course of 8 to 10 days with increasing
metronidazole concentration in the growth medium (from 2 µg/ml to 25 µg/ml). The metronidazole MIC for nine independently selected
69A/Mtzr and 503/Mtzr
strains was >25 µg/ml, while that for strains 503 and 69A was <5
µg/ml (data not shown). These results correspond to the observation of metronidazole resistance developing de novo during the course of a
typical antibiotic therapy (1). In vitro selection of amoxicillin-resistant H. pylori strains was done similarly.
Since the amoxicillin MIC for strains 503 and 69A was 0.02 to 0.05 µg/ml, we began selection at an amoxicillin concentration of 0.01 µg/ml. After 11 passages and 35 days under the permanent selective
pressure of amoxicillin, the amoxicillin MIC for strain 69A reached 0.5 to 1 µg/ml, and after 35 passages and 89 days, an amoxicillin MIC of
15 µg/ml for the highly resistant strain
69A/Amxr was obtained. Comparable
selection results were obtained for the strain 503 (data not shown). In
contrast to other Amxr strains described in the
literature (9), the resistance was stable after
cultivation in the absence of antibiotics and storage at
80°C. The
induction of resistance was specific for the antibiotic used for
selection. Amoxicillin-resistant strains remained sensitive to
metronidazole and vice versa.
To investigate the molecular mechanisms for resistance, we sequenced
putative resistance genes from 69A strains: five independently selected
69A/Mtzr strains and one
69A/Amxr strain. The rdxA gene of each
69A/Mtzr strain had at least one mutation
compared to the copy of the wild-type 69A strain (Fig.
1A). In three cases, the mutations caused
stop codons in the rdxA open reading frame, which is also common for metronidazole-resistant clinical isolates (Fig. 1B). In the
remaining two strains, the mutations caused either one or two amino
acid changes at positions conserved in metronidazole-sensitive strains
(Fig. 1B). The 69A/Amxr strain had no
rdxA mutation (Fig. 1A), but had four pbp1
mutations (S414R, Y484C, T541I, and P600T) and one pbp2
mutation (T498I). All of these mutations cause amino acid changes at
positions conserved in the Amxs strains 26695 (16), J99 (2), and 69A (GenBank accession no.
AF315503 and AF315504) and were located in the putative transpeptidase
domains of the proteins (10).

View larger version (76K):
[in this window]
[in a new window]
|
FIG. 1.
Alignment of RdxA proteins from H. pylori
69A strains selected for antibiotic resistance (A) and those of
H. pylori wild-type strains (B). (A) The strains 69A and
69A/Amxr were metronidazole sensitive, and the
69A/Mtzr1 to -5 strains were metronidazole resistant. (B)
H. pylori strains 26695, 503, 69A, and 500 were
metronidazole sensitive, and H. pylori strains 439 and
504 (ATCC 43504) were metronidazole resistant. A black background shows
the conservation of amino acid residues. H. pylori amino
acid sequences are given as follows: 26695, reference 16;
strains 500 and 439, reference 11; strain 503, GenBank
accession no. AF316109; strain 504, accession no. AF315501; and strain
69A, accession no. AF315502.
|
|
To prove that these mutations were indeed responsible for antibiotic
resistance, we amplified these genes by PCR, purified the DNA by gel
electrophoresis, and transformed it into antibiotic-sensitive strains.
To do this, we used a simplified protocol for transformation of
H. pylori, in which we added linear PCR fragments without an additional resistance marker to logarithmically growing H. pylori and then selected for transformants with amoxicillin or
metronidazole, respectively. After transformation with the mutated
rdxA genes from four 69A/Mtzr strains,
bacteria of three metronidazole-sensitive H. pylori strains
(26695, 69A, and 888-0) were rendered resistant (Table 1). Transformation with the mutated
pbp1 gene from the 69A/Amxr strain
rendered bacteria of these strains (26695, 69A, and 888-0) moderately
amoxicillin resistant (MIC of 0.5 to 1 µg/ml). Transformation with
the pbp2 gene from 69A/Amxr caused no
amoxicillin resistance. The cotransformation of pbp1 and
pbp2 did not show increased resistance compared to
transformation with pbp1 alone (Table 1).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Transformation of mutated genes into antibiotic-sensitive
H. pylori with metronidazole or amoxicillin
selection mediuma
|
|
To exclude the possibility that antibiotic resistance after
transformation was due to a different spontaneous mutation, we sequenced the rdxA genes from six transformed
metronidazole-resistant strains and the pbp1 genes from two
transformed amoxicillin-resistant strains. In all but one case, we
found the same mutations as in the respective donor strain (Table
2). The only exception was observed for
transformation with the rdxA gene of
69A/Mtzr4: The rdxA gene from
69A/Mtzr4 contained two mutations (C19Y and
C184F), while H. pylori transformed with this gene acquired
only the C19Y mutation (Table 2). We therefore do not know if the C184F
mutation is involved in metronidazole resistance.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Sequences of rdxA and pbp1 genes
from antibiotic-resistant H. pylori strains gained by
transformation with mutated rdxA and pbp1 genes
|
|
Our findings independently confirm previous results (7, 11,
14) and expand their data in the sense that not only stop codons
and extensive deletions in the rdxA open reading frame cause
metronidazole resistance, but so do single amino acid changes. We have
proven that two alterations of the RdxA protein, C19Y and T49K, have
the same effect on the phenotype of H. pylori
(Mtzs
Mtzr) as
rdxA null mutations and conclude that they severely affect RdxA function. The same is true for deletion of the C-terminal 14 amino
acids of RdxA. By systematically transforming rdxA genes with single mutations into metronidazole-sensitive H. pylori
strains by the simplified protocol, we have illustrated how it would be possible to identify additional residues essential for RdxA function. We have also shown that pbp1 mutations can affect
amoxicillin resistance, but are not sufficient for the high-level
amoxicillin resistance of 69A/Amxr. This
indicates that mutations in more than one gene are probably required to
render H. pylori amoxicillin resistant. This could explain
the many cycles necessary for the in vitro selection of amoxicillin-resistant H. pylori strains and their low
occurrence in vivo.
 |
ACKNOWLEDGMENTS |
The work described here was supported by a grant from the German
Ministry of Education and Research (BMBF; BEO/22 031 0777).
We thank Klaus Bensch and Wolfram Steinhilber for discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Yale University,
266 Whitney Ave., New Haven, CT 06511. Phone: (203) 432-3506. Fax: (203) 432-5713. E-mail: Ralf.Paul{at}Yale.edu.
 |
REFERENCES |
| 1.
|
Adamek, R. J.,
S. Suerbaum,
B. Pfaffenbach, and W. Opferkuch.
1998.
Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin influence on treatment outcome.
Am. J. Gastroenterol.
93:386-389[Medline].
|
| 2.
|
Alm, R. A.,
L. S. Ling,
D. T. Moir,
B. L. King,
E. D. Brown,
P. C. Doig, et al.
1999.
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.
Nature
397:176-180[CrossRef][Medline].
|
| 3.
|
Blaser, M. J.
1997.
Not all Helicobacter pylori strains are created equal: should all be eliminated?
Lancet
349:1020-1022[CrossRef][Medline].
|
| 4.
|
Blaser, M. J.
1998.
Helicobacter pylori and gastric diseases.
Br. Med. J.
316:1507-1510[Free Full Text].
|
| 5.
|
Davies, J.
1994.
Inactivation of antibiotics and the dissemination of resistance genes.
Science
264:375-382[Abstract/Free Full Text].
|
| 6.
|
Debets-Ossenkopp, Y. J.,
A. J. Herscheid,
R. G. Pot,
E. J. Kuipers,
J. G. Kusters, and C. M. Vandenbroucke-Grauls.
1999.
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline and trovafloxacin in The Netherlands.
J. Antimicrob. Chemother.
43:511-515[Abstract/Free Full Text].
|
| 7.
|
Debets-Ossenkopp, Y. J.,
R. G. J. Pot,
D. J. van Westerloo,
A. Goodwin,
C. M. J. E. Vandenbroucke-Grauls,
D. E. Berg,
P. S. Hoffman, and J. G. Kusters.
1999.
Insertion of mini-IS605 and deletion of adjacent sequences in the nitroreductase (rdxA) gene cause metronidazole resistance in Helicobacter pylori NCTC11637.
Antimicrob. Agents Chemother.
43:2657-2662[Abstract/Free Full Text].
|
| 8.
|
Dore, P. M.,
A. Piana,
M. Carta,
A. Atzei,
B. M. Are,
I. Mura, et al.
1998.
Amoxicillin resistance is one reason for failure of amoxicillin-omeprazole treatment of Helicobacter pylori infection.
Aliment. Pharmacol. Ther.
12:635-639[CrossRef][Medline].
|
| 9.
|
Dore, P. M.,
D. Y. Graham, and A. R. Sepulveda.
1999.
Different penicillin-binding protein profiles in amoxicillin-resistant Helicobacter pylori.
Helicobacter
4:154-161[CrossRef][Medline].
|
| 10.
|
Goffin, C., and J. M. Ghuysen.
1998.
Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs.
Microbiol. Mol. Biol. Rev.
62:1079-1093[Abstract/Free Full Text].
|
| 11.
|
Goodwin, A.,
D. Kersulyte,
G. Sisson,
S. J. Veldhuyzen van Zanten,
D. E. Berg, and P. S. Hoffman.
1998.
Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase.
Mol. Microbiol.
28:383-393[CrossRef][Medline].
|
| 12.
|
Sörberg, M.,
H. Hanberger,
M. Nilsson,
A. Björkman, and L. E. Nilsson.
1998.
Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori.
Antimicrob. Agents Chemother.
42:1222-1228[Abstract/Free Full Text].
|
| 13.
|
Spratt, B. G.
1994.
Resistance to antibiotics mediated by target alterations.
Science
264:388-393[Abstract/Free Full Text].
|
| 14.
|
Tankovic, J.,
D. Lamarque,
J.-C. Delchier,
C.-J. Soussy,
A. Labigne, and P. J. Jenks.
2000.
Frequent association between alteration of the rdxA gene and metronidazole resistance in French and North African isolates of Helicobacter pylori.
Antimicrob. Agents Chemother.
44:608-613[Abstract/Free Full Text].
|
| 15.
|
Tenney, J. H.,
R. W. Maack, and G. R. Chippendale.
1983.
Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.
Antimicrob. Agents Chemother.
23:188-189[Abstract/Free Full Text].
|
| 16.
|
Tomb, J. F.,
O. White,
A. R. Kerlavage,
R. A. Clayton,
G. G. Sutton,
R. D. Fleischmann, et al.
1997.
The complete genome sequence of the gastric pathogen Helicobacter pylori.
Nature
388:539-547[CrossRef][Medline].
|
Antimicrobial Agents and Chemotherapy, March 2001, p. 962-965, Vol. 45, No. 3
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.3.962-965.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Co, E.-M. A., Schiller, N. L.
(2006). Resistance Mechanisms in an In Vitro-Selected Amoxicillin-Resistant Strain of Helicobacter pylori. Antimicrob. Agents Chemother.
50: 4174-4176
[Abstract]
[Full Text]
-
Megraud, F
(2004). H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut
53: 1374-1384
[Full Text]
-
Kwon, D. H., Dore, M. P., Kim, J. J., Kato, M., Lee, M., Wu, J. Y., Graham, D. Y.
(2003). High-Level {beta}-Lactam Resistance Associated with Acquired Multidrug Resistance in Helicobacter pylori. Antimicrob. Agents Chemother.
47: 2169-2178
[Abstract]
[Full Text]
-
Okamoto, T., Yoshiyama, H., Nakazawa, T., Park, I.-D., Chang, M.-W., Yanai, H., Okita, K., Shirai, M.
(2002). A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori. J Antimicrob Chemother
50: 849-856
[Abstract]
[Full Text]
-
Gerrits, M. M., Schuijffel, D., van Zwet, A. A., Kuipers, E. J., Vandenbroucke-Grauls, C. M. J. E., Kusters, J. G.
(2002). Alterations in Penicillin-Binding Protein 1A Confer Resistance to {beta}-Lactam Antibiotics in Helicobacter pylori. Antimicrob. Agents Chemother.
46: 2229-2233
[Abstract]
[Full Text]